Literature DB >> 7339817

The seroagglutination test in the study of nontuberculous mycobacteria.

J K McClatchy.   

Abstract

The Schaefer seroagglutination test is useful in epidemiologic studies of nontuberculous mycobacteria, especially the Mycobacterium avium-intracellulare-scrofulaceum complex. Serovars 8, 16, 4, 19, 9, 42, and 1 were isolated most frequently from patients in the United States in the period 1976 to mid-1978. Several so-called double serovars were found serologically. It appears that this is an artifact due to cross-reacting antigens, because only one antigen is seen using chromatographic analyses. Further development of this system and its use in conjunction with other methods offer a valuable method for the study of nontuberculous mycobacteria.

Entities:  

Mesh：

Year:  1981        PMID： 7339817     DOI： 10.1093/clinids/3.5.867

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN： 0162-0886


  18 in total

Review 1.  AIDS-related mycobacterial disease.

Authors:  F M Collins
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Arylsulfatase activity for differentiating Mycobacterium avium and Mycobacterium intracellulare.

Authors:  H Tomioka; H Saito; K Sato; D J Dawson
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

3.  Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome.

Authors:  M A Yakrus; R C Good
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

5.  Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits.

Authors:  M Emori; H Saito; K Sato; H Tomioka; T Setogawa; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Implications of antibodies to pyruvylated glucose in healthy populations for mycobacterioses and other infectious diseases.

Authors:  W R Thayer; C M Bozic; R T Camphausen; M McNeil
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

7.  Antibodies to mycobacterial peptidoglycolipid and to crude protein antigens in sera from different categories of human subjects.

Authors:  L G Wayne; B Anderson; K Chetty; R W Light
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

8.  Comprehensive approach to identification of serovars of Mycobacterium avium complex.

Authors:  J C Denner; A Y Tsang; D Chatterjee; P J Brennan
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  Clinical and epidemiological importance of typing of Mycobacterium avium complex isolates.

Authors:  A Y Tsang; J C Denner; P J Brennan; J K McClatchy
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

10.  Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.

Authors:  C R Horsburgh; D L Cohn; R B Roberts; H Masur; R A Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.